Tasly Pharmaceutical Group Co., Ltd.
- Country
- 🇨🇳China
- Ownership
- Public, Subsidiary
- Established
- 1998-04-30
- Employees
- 9.2K
- Market Cap
- -
- Website
- https://www.taslypharma.com
A Study of Qishenyiqi Dripping Pills in Healthy Participants
- Conditions
- Healthy Participants
- Interventions
- Drug: Qishenyiqi dripping pills, 6 bagsDrug: Qishenyiqi dripping pills, 9 bagsDrug: Qishenyiqi dripping pills, 12 bagsDrug: Qishenyiqi dripping pills placebo, 6 bagsDrug: Qishenyiqi dripping pills placebo, 9 bagsDrug: Qishenyiqi dripping pills placebo, 12 bags
- First Posted Date
- 2020-07-15
- Last Posted Date
- 2021-07-14
- Lead Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT04471298
- Locations
- 🇨🇳
The First Teaching Hospital of Tianjin University of TCM, Tianjin, Tianjin, China
Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in Children
- Conditions
- Cough
- Interventions
- Drug: High dose Susu Xiao'er Zhike Granules 1 bagDrug: Middle dose Susu Xiao'er Zhike Granules 1 bagDrug: Extremely-low dose Susu Xiao'er Zhike Granules 1 bag
- First Posted Date
- 2020-07-07
- Last Posted Date
- 2020-09-29
- Lead Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 240
- Registration Number
- NCT04457011
- Locations
- 🇨🇳
Xiamen Hospital of Traditional Chinese Medicine, Xiamen, Fujian, China
🇨🇳Hubei Provincial Hospital of TCM, Wuhan, Hubei, China
🇨🇳The First Hospital of Hunan University of Traditional Chinese Medicine, Changsha, Hunan, China
A Study of Xiangjurupining Capsule in the Treatment of Hyperplasia of Breast (Liver Stagnation and Phlegm Coagulation)
- Conditions
- Hyperplasia of Breast
- Interventions
- Drug: High dose Xiang Ju Ru Pi Ning capsuleDrug: Low dose Xiang Ju Ru Pi Ning capsuleDrug: Xiang Ju Ru Pi Ning capsule placebo
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 180
- Registration Number
- NCT04229706
- Locations
- 🇨🇳
Baoding No.1 Hospital of TCM, Baoding, China
🇨🇳the First Affiliated Hospital of Guangzhou University of TCM, Guangzhou, China
🇨🇳Dongfang Hospital ,Beijing University of Chinese Medicine, Beijing, China
A Study to Evaluate the Tolerability and Pharmacokinetics of Jiashen Tablets in Healthy Subjects
- First Posted Date
- 2019-11-15
- Last Posted Date
- 2022-11-23
- Lead Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 70
- Registration Number
- NCT04164290
- Locations
- 🇨🇳
The second affiliated hospital of tianjin university of traditional Chinese medicine, Tianjin, Tianjin, China
Study of Jitongning Tablet to Treat Spondyloarthritis
- Conditions
- Spondyloarthritis
- Interventions
- Drug: Jitongning tablet(High-dose )Drug: Jitongning tablet(Low-dose )Drug: Placebo
- First Posted Date
- 2019-04-30
- Last Posted Date
- 2022-11-21
- Lead Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 238
- Registration Number
- NCT03932019
- Locations
- 🇨🇳
The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, Anhui, China
🇨🇳The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong, China
🇨🇳The First Affiliated Hospital of hunan Medical University, Changsha, Hunan, China